Key result
Rivaroxaban therapy resulted in the successful resolution of a large left atrial appendage thrombus after 3 months in a 79-year-old male with atrial fibrillation.
Why the study?
Limited data are available to support the use of rivaroxaban for the treatment of intracardiac thrombi.
Does rivaroxaban resolve left atrial appendage thrombus in a patient with atrial fibrillation?
Case Report (n=1)
Does rivaroxaban resolve left atrial appendage thrombus in a patient with atrial fibrillation?
This case demonstrates that rivaroxaban may be an effective alternative to warfarin for the resolution of left atrial appendage thrombi.
No takes yet. Share an insight, caveat, or question.
Single case of LAA thrombus resolution on rivaroxaban should not change practice; leaves open need for randomized trials.
Gaznabi et al. (2019) conducted a case report in Left atrial appendage thrombus in atrial fibrillation (n=1). Rivaroxaban was evaluated on Resolution of thrombus on repeat transesophageal echocardiogram. Rivaroxaban therapy resulted in the successful resolution of a large left atrial appendage thrombus after 3 months in a 79-year-old male with atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: